Text Size
439 studies found for:    glioma | Open Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT
Condition: Glioma
Intervention: Drug: [68Ga]DOTATOC
22 Recruiting Study to Evaluate the Effects of Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent/Post-Chemotherapy WHO Grade II Gliomas
Conditions: High Risk WHO Grade II Glioma;   Recurrent/Post-Chemotherapy WHO Grade II Glioma
Interventions: Biological: Tumor Lysate Vaccine;   Drug: Imiquimod
23 Recruiting Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
Conditions: Brain Cancer;   Brain Stem Glioma
Intervention: Radiation: Radioactive iodine-labeled monoclonal antibody 8H9
24 Recruiting Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
Conditions: Glial Cell Tumors;   Malignant Gliomas;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliomatosis Cerebri;   Gliosarcoma;   Brainstem Glioma
Interventions: Drug: Valproic acid;   Drug: Bevacizumab;   Radiation: Radiation therapy
25 Recruiting An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Conditions: Brain Metastases;   Lung Cancer;   Breast Cancer;   Melanoma;   Malignant Glioma
Interventions: Drug: 2B3-101;   Drug: Trastuzumab
26 Unknown † Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
Condition: Glioma Patients
Intervention: Drug: Bevacizumab
27 Recruiting Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
Conditions: Anaplastic Astrocytoma;   Anaplastic Ependymoma;   Anaplastic Meningioma;   Anaplastic Oligodendroglioma;   Brain Stem Glioma;   Ependymoblastoma;   Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma;   Grade III Meningioma;   Meningeal Hemangiopericytoma;   Mixed Glioma;   Pineal Gland Astrocytoma;   Brain Tumor
Interventions: Biological: therapeutic allogeneic lymphocytes;   Biological: aldesleukin;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography
28 Recruiting Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme;   GBM;   Brain Cancer
Intervention: Drug: VAL-083
29 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation resection
30 Recruiting Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant Glioma
Condition: Recurrent Malignant Glioma
Intervention: Drug: Bevacizumab / Irinotecan
31 Unknown † Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Condition: Glioma
Intervention: Biological: GM-K562 Vaccination
32 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
33 Recruiting Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Condition: Glioma
Intervention: Drug: nilotinib
34 Recruiting Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Conditions: Brain Cancer;   MALIGNANT GLIOMA;   Glioblastoma;   Anaplastic Astrocytoma (AA);   Anaplastic Oligodendroglioma (AO);   Anaplastic Oligo-astrocytoma (AOA);   Anaplastic Mixed Gliomas;   Malignant Glioma NOS
Intervention: Other: Bevacizumab & stereotactic radiotherapy
35 Recruiting Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma
Condition: Grade IV Malignant Glioma
Intervention: Biological: ALD-451
36 Not yet recruiting Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma
Condition: Malignant Glioma
Intervention: Biological: Biological: DC activated CIK combined with DC
37 Recruiting Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
Conditions: Adult Diffuse Astrocytoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Recurrent Adult Brain Tumor;   Adult Oligoastrocytoma
Interventions: Biological: tumor lysate-pulsed autologous dendritic cell vaccine;   Other: laboratory biomarker analysis
38 Recruiting Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
Condition: Pediatric High Risk Gliomas
Intervention: Drug: Combination of two marketed drugs (irinotecan and cisplatin)
39 Recruiting A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Condition: Glioma
Interventions: Drug: LY2157299;   Drug: Radiation;   Drug: Temozolomide
40 Recruiting Image Guided Therapy in the Treatment of Gliomas
Condition: Glioma
Interventions: Procedure: Diffusion-weighted magnetic resonance imaging;   Procedure: Perfusion-weighted magnetic resonance imaging;   Procedure: Functional magnetic resonance imaging;   Procedure: Magnetic resonance spectroscopic imaging;   Procedure: Therapeutic conventional surgery;   Procedure: Quality-of-life assessment;   Radiation: Radiation therapy treatment planning/simulation;   Radiation: Intensity-modulated radiation therapy;   Other: Questionnaire administration
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years